"We're here for your heart care needs. Birmingham Heart Clinic at Ascension St. Vincent's in Birmingham, Alabama, offers a wide range of diagnostic cardiac imaging and tests. We work with you to help prevent heart attack or stroke, and we help you manage high blood pressure, high cholesterol and irregular heartbeats. We specialize in caring for many heart conditions, including AFib, congestive heart failure, structural heart and valve care, peripheral artery disease, and coronary artery blockages. If you are experiencing chest pain or stroke symptoms, go to the nearest ER and call 9-1-1. Our Ascension St. Vincent's Hospital ER doctors and cardiologists work quickly to understand your condition and deliver the care you need."

During the past decade, Birmingham Heart Clinic, P.C. conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Birmingham Heart Clinic, P.C." #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "ARYx Therapeutics" with 1 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Abbott Nutrition" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Birmingham Heart Clinic, P.C." #1 collaborator was "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Daiichi Sankyo, Inc." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Birmingham Heart Clinic, P.C." are "Atrial Fibrillation" (2 trials), "Atrial Flutter" (2 trials), "Cardiovascular Disease" (2 trials), "Coronary Artery Disease" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Birmingham Heart Clinic, P.C." in a lesser frequency.

Most popular intervention types in "Birmingham Heart Clinic, P.C." are "Drug" (6 trials), "Device" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "ACUITY Spiral Left Ventricular Lead" (1 trials), "ATI-5923" (1 trials) and "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Birmingham Heart Clinic, P.C." are 11 trials for "All" genders.

Currently, there are NaN active trials in "Birmingham Heart Clinic, P.C.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Birmingham Heart Clinic, P.C., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Birmingham Heart Clinic, P.C., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".